JessicaAnn KangMeznarichMD

Pediatric Hematology & Oncology • Salt Lake City, UT

Physician

Join to view full profile

Dr. Meznarich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meznarich's full profile

Already have an account?

Office
100 N Mario Capecchi Dr
Salt Lake City, UT 84113
Phone+1 801-662-1000

Fax+1 801-662-4707

Education & Training

University of Utah HealthFellowship, Pediatric Hematology/Oncology, 2013 - 2016
University of Utah HealthResidency, Pediatrics, 2010 - 2013
University of Washington School of MedicineClass of 2010

Certifications & Licensure

UT State Medical License 2011 - 2026
CO State Medical License 2023 - 2025
ID State Medical License 2023 - 2025
MT State Medical License 2016 - 2025
NV State Medical License 2023 - 2025
WY State Medical License 2023 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

16 citations
VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects
Katie G. Seu, Lisa Trump, Sana Emberesh, Robert B. Lorsbach, Clarissa E. Johnson
American Journal of Human Genetics. 2020-12-03
37 citations
Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
April Stempien-Otero, A. R. Plawman, Jessica Meznarich, Teja Dyamenahalli, Goro Otsuka
The Journal of Biological Chemistry. 2006-06-02
5 citations
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)
Omar Niss, Robert B. Lorsbach, Mikaela Berger, Satheesh Chonat, Morgan L. McLemore
Blood Cells, Molecules & Diseases. 2021-03-01

Abstracts/Posters

VPS4A mutations Cause a Syndrome with Dyserythropoiesis, Hemolytic Anemia, and Neurodevelopmental Delay
Jessica Meznarich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
Jessica Meznarich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019